Business

Novo Nordisk Exceeds Forecasts with Wegovy Sales

Updated 2026-05-06 07:00 UTC 1 source Positive

Novo Nordisk surpassed its sales forecasts for the newly launched Wegovy pill, prompting a hike in its guidance. The strong performance is expected to boost company earnings and market expectations.

Coverage timeline — 2 articles

CNBC

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

2026-05-06 06:46 UTC

CNBC

CNBC's UK Exchange newsletter: It's not the 1970s, but the oil shock is still biting hard

In theory, the U.K. should be less exposed to the impact of higher energy prices than some peers. In practice, the price surge is having a dire impact.

2026-05-06 06:49 UTC